Recent Quotes (30 days)

You have no recent quotes
chg | %

Annidis Corp  

(Public, CVE:RHA)   Watch this stock  
Find more results for RHA
0.0000 (0.00%)
Oct 18 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.01 - 0.01
52 week 0.00 - 0.04
Open 0.01
Vol / Avg. 525,000.00/5,900.00
Mkt cap 1.10M
P/E     -
Div/yield     -
EPS -0.04
Shares 109.95M
Beta -0.88
Inst. own     -
Nov 20, 2017
Q3 2017 Annidis Corp Earnings Release (Estimated) Add to calendar
Aug 25, 2017
Q2 2017 Annidis Corp Earnings Release

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin -88.81% -428.95%
Operating margin -76.93% -289.84%
EBITD margin - -274.61%
Return on average assets -89.59% -193.89%
Return on average equity - -
CDP Score - -


100 Maple Grove Rd
+1-613-5961800 (Phone)
+1-613-5969453 (Fax)

Website links


Annidis Corporation develops and markets imaging technologies to eye care professionals. The Company has developed a multi-spectral imaging (MSI) system for retinal and choroidal assessment (the RHA). The RHA provides eye-care professionals with a screening tool for early detection and diagnosis of a range of pathologies. The RHA is an ocular pathology management system that integrates MSI with analytic software and management of ocular pathologies, such as glaucoma, age-related macular degeneration and diabetic retinopathy. Its RHA collects and combines multi-spectral information. The RHA is a non-invasive instrument that uses MSI to take pictures of the retinal layers of eye. The images are then processed using the RHA Report software to reveal various layers in the back of the eye. The Company is also engaged in developing RHA Platinum, which is under development with beta units in clinical testing that allows doctors to visualize choroidal and retinal vasculature non-invasively.

Officers and directors

Gerald Slemko Executive Chairman of the Board, Interim Chief Executive Officer
Age: 63
Brian Baker Chief Financial Officer
Michael Francis Crowley Director
Zeljko Ribaric Director
Ying Zhi Gu Independent Director
Chunhang Yu Independent Director
Jinsong Zhang Independent Director